Mc2 Drug Patent Portfolio
Mc2 owns 1 orange book drug protected by 4 US patents Given below is the list of Mc2's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11638711 | NULL | 18 Mar, 2039 | Active |
| US11696919 | Topical composition | 18 Mar, 2039 | Active |
| US12440499 | 18 Mar, 2039 | Active | |
| US10265265 | Topical composition | 27 Sep, 2027 | Active |
Latest Legal Activities on Mc2's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mc2.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eCofC Notification | 19 Mar, 2024 | US11638711 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11638711 |
| Mail Patent eCofC Notification | 19 Mar, 2024 | US11696919 |
| Recordation of Patent eCertificate of Correction | 19 Mar, 2024 | US11638711 |
| Recordation of Patent eCertificate of Correction | 19 Mar, 2024 | US11696919 |
| Patent eCofC Notification | 19 Mar, 2024 | US11696919 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11696919 |
| Mail Patent eCofC Notification | 19 Mar, 2024 | US11638711 |
| Mail Certificate of Correction Memo | 28 Feb, 2024 | US11638711 |
| Post Issue Communication - Certificate of Correction | 28 Feb, 2024 | US11638711 |
| Mail Certificate of Correction Memo | 28 Feb, 2024 | US11696919 |
| Post Issue Communication - Certificate of Correction | 28 Feb, 2024 | US11696919 |
| Certificate of Correction Memo | 26 Feb, 2024 | US11638711 |
| Certificate of Correction Memo | 26 Feb, 2024 | US11696919 |
| Mail Patent eGrant Notification | 11 Jul, 2023 | US11638711 |
Mc2's Family Patents
Mc2 Drug List
Given below is the complete list of Mc2's drugs and the patents protecting them.
1. Wynzora
Wynzora is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11638711 | NULL |
18 Mar, 2039
(13 years from now)
| Active |
| US11696919 | Topical composition |
18 Mar, 2039
(13 years from now)
| Active |
| US12440499 |
18 Mar, 2039
(13 years from now)
| Active | |
| US10265265 | Topical composition |
27 Sep, 2027
(1 year, 9 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wynzora's drug page